製品番号: HY-N7844

N6-Benzyladenosine

(別名: Benzyladenosine; N6-ベンジルアデノシン)

カスタマーレビュー

Based on 1 Customer Validation

N6-Benzyladenosine is an adenosine receptor agonist, has a cytoactive activity. N6-Benzyladenosine arrests cell cycle at G0/G1 phase and induces cell apoptosis. N6-Benzyladenosine also exerts inhibitory effect on T. gondii adenosine kinase and glioma^-.

商品は「研究用試薬」です。人や動物の医療用・臨床診断用・食品用の製品ではありません。
研究用途以外に使用した場合、当社は一切の責任を負いかねます。

純度: 99.72%
CAS 番号: 4294-16-0
分子式: C₁₇H₁₉N₅O₄
分子量:357.36

保管条件:

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

N6-Benzyladenosine 構造式

CAS 番号: 4294-16-0

容量

価格（税別）

在庫状況

数量

Amount: USD 0.00

* アイテムを追加する前、数量をご選択ください

Top Publications Citing

Use of MCE Products

Fluorescent Dye

Strong Fluorescence Signal / Multi-Disciplinary Applications / High Fluorescence Specificity

生物活性

製品説明

Adenosine Receptor アイソフォーム固有の製品をすべて表示 :

Cellular Effect

Cell Line	Type	Value	Description	References
B16	IC₅₀	>166.7 μM Compound: BAPR	Antitumor activity against mouse B16 cells after 72 hrs by Calcein AM assay Antitumor activity against mouse B16 cells after 72 hrs by Calcein AM assay	[PMID: 17418578]
Caco-2	GI₅₀	7.4 μM Compound: 19, BnA	Antitumor activity against human CaCo2 cells after 48 hrs by MTS assay Antitumor activity against human CaCo2 cells after 48 hrs by MTS assay	[PMID: 18588281]
CCRF-CEM	IC₅₀	1.4 μM Compound: BAPR	Antitumor activity against human CEM cells after 72 hrs by Calcein AM assay Antitumor activity against human CEM cells after 72 hrs by Calcein AM assay	[PMID: 17418578]
G-361	IC₅₀	>166.7 μM Compound: BAPR	Antitumor activity against human G361 cells after 72 hrs by Calcein AM assay Antitumor activity against human G361 cells after 72 hrs by Calcein AM assay	[PMID: 17418578]
HL-60	IC₅₀	0.94 μM Compound: BAPR	Antitumor activity against human HL60 cells after 72 hrs by Calcein AM assay Antitumor activity against human HL60 cells after 72 hrs by Calcein AM assay	[PMID: 17418578]
HOS	IC₅₀	>166.7 μM Compound: BAPR	Antitumor activity against human HOS cells after 72 hrs by Calcein AM assay Antitumor activity against human HOS cells after 72 hrs by Calcein AM assay	[PMID: 17418578]
HT-29	GI₅₀	22.3 μM Compound: 19, BnA	Antitumor activity against human HT29 cells after 48 hrs by MTS assay Antitumor activity against human HT29 cells after 48 hrs by MTS assay	[PMID: 18588281]
K562	GI₅₀	2.92 μM Compound: 19, BnA	Growth inhibition of 0.1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 72 hrs by MTS assay Growth inhibition of 0.1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 72 hrs by MTS assay	[PMID: 18588281]
K562	GI₅₀	2.92 μM Compound: 19, BnA	Growth inhibition of 1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 72 hrs by MTS assay Growth inhibition of 1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 72 hrs by MTS assay	[PMID: 18588281]
K562	GI₅₀	3.91 μM Compound: 19, BnA	Growth inhibition of 0.1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 48 hrs by MTS assay Growth inhibition of 0.1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 48 hrs by MTS assay	[PMID: 18588281]
K562	GI₅₀	4.17 μM Compound: 19, BnA	Growth inhibition of 1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 48 hrs by MTS assay Growth inhibition of 1 uM 1,4-dihydro-2-methyl-6-phenyl-4-(phenylethyl)-3,5-pyridine-dicarboxylic acid 3-ethyl-5-[(3-nitrophenyl) methyl] ester pretreated human K562 cells after 48 hrs by MTS assay	[PMID: 18588281]
K562	GI₅₀	4.6 μM Compound: 19, BnA	Antitumor activity against human K562 cells after 48 hrs by MTS assay Antitumor activity against human K562 cells after 48 hrs by MTS assay	[PMID: 18588281]
K562	IC₅₀	5.5 μM Compound: BAPR	Antitumor activity against human K562 cells after 72 hrs by Calcein AM assay Antitumor activity against human K562 cells after 72 hrs by Calcein AM assay	[PMID: 17418578]
MCF7	GI₅₀	61 μM Compound: 19, BnA	Antitumor activity against human MCF7 cells after 48 hrs by MTS assay Antitumor activity against human MCF7 cells after 48 hrs by MTS assay	[PMID: 18588281]
NIH3T3	IC₅₀	39 μM Compound: BAPR	Cytotoxicity against mouse NIH 3T3 cells after 72 hrs by Calcein AM assay Cytotoxicity against mouse NIH 3T3 cells after 72 hrs by Calcein AM assay	[PMID: 17418578]
Platelet	IC₅₀	37.12 μM Compound: 2d	Inhibition of collagen-induced human platelet aggregation after 3 mins by light transmission aggregometry Inhibition of collagen-induced human platelet aggregation after 3 mins by light transmission aggregometry	[PMID: 25467153]
RD	CC₅₀	4 μM Compound: 23	Cytotoxicity against human RD cells Cytotoxicity against human RD cells	[PMID: 26854380]
RD	EC₅₀	0.28 μM Compound: 23	Antiviral activity against Enterovirus 71 infected in human RD cells assessed as cell viability after 3 days by MTS assay Antiviral activity against Enterovirus 71 infected in human RD cells assessed as cell viability after 3 days by MTS assay	[PMID: 26854380]

体外実験

N6-benzyladenosine suppresses the clonogenic activity and the growth of different neoplastic cells^[2].
N6-benzyladenosine results cell morphology alteration and actin cytoskeleton disorganization in T24 cell^[2].
N6-benzyladenosine (10 μM; 24 h) is a potent inductor of apoptosis, and belongs to apoptotic systems with distinct caspase-3 and caspase-9 activation^[3].
N6-benzyladenosine (0-100 μM; 24 h) induces chromatin condensation, formation of apoptotic bodies, and cleavage of DNA to nucleosomal fragments in a dose-dependent manner^[3].
N6-benzyladenosine acts as a selective anti-toxoplasma agent with binding affinity to T. gondii adenosine kinase (apparent K_m =179.8 μM), over human adenosine kinase^[4].
N6-benzyladenosine (0-50 μM) shows weak inhibition against adenosine kinase deficient (TgAKS3) strains of Toxoplasma gondii^[4].
N6-benzyladenosine (compound 2) (0.3-20 μM) exerts anti-glioma activity by interfering with the mevalonate pathway and inhibiting FPPS (Farnesyl pyrophosphate synthase) ^[5].

MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.

Apoptosis Analysis^[3]

Cell Line:

HL-60
Concentration:

10 μM
Incubation Time:

24 hours
Result:

Induced cell apoptosis by increasing caspase-3 (DEVDase) as well as caspase-9 (LEHDase) activity, indicating an apoptotic systems with distinct caspase-3/9 activation.

Apoptosis Analysis^[5]

Cell Line:

U87MG human glioma cell line.
Concentration:

0.3, 0.6, 1.2, 2.5, 5, 10, 20 μM
Incubation Time:

48 hours
Result:

Inhibited glioma growth by interfering with the mevalonate pathway and inhibiting FPPS.

化学情報

CAS 番号 4294-16-0
性状 Solid
分子量 357.36
分子式 C₁₇H₁₉N₅O₄
Color White to off-white
SMILES

O[C@H]1[C@@H](O)[C@H](N2C(N=CN=C3NCC4=CC=CC=C4)=C3N=C2)O[C@@H]1CO
別名

Benzyladenosine; N6-ベンジルアデノシン
Structure Classification
- Others
Initial Source
- Plants
- Umbelliferae
輸送条件

Room temperature in continental US; may vary elsewhere.
保管条件

4°C, protect from light

* In solvent : -80°C, 6 months; -20°C, 1 month (protect from light)

溶剤 & 溶解度

体外:

DMSO : 125 mg/mL (349.79 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)

View the Complete Stock Solution Preparation Table

Preparing Stock Solutions

View the Complete Stock Solution Preparation Table

Concentration Solvent Mass

1 mg

5 mg

10 mg

Concentration

Solvent

Mass

1 mM

2.7983 mL

13.9915 mL

27.9830 mL

5 mM

0.5597 mL

2.7983 mL

5.5966 mL

10 mM

0.2798 mL

1.3991 mL

2.7983 mL

Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.

Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month (protect from light). When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.

モル濃度計算機

Mass (g) = Concentration (mol/L) × Volume (L) × Molecular Weight (g/mol)

Mass Mass

濃度濃度

体積体積

分子量分子量

希釈計算機

濃度 _(開始) × 体積 _(開始) = 濃度 _(終了) × 体積 _(終了)

濃度 _(開始) 濃度 _(開始)

体積 _(開始) 体積 _(開始)

濃度 _(終了) 濃度 _(終了)

体積 _(終了) 体積 _(終了)

純度とドキュメンテーション

バッチを選択:

純度: 99.98%

Assay: 99.98%

ee.: 99.98%

データシート (278 KB)
SDS (394 KB)
- English - EN (394 KB)
- Français - FR (394 KB)
- Deutsch - DE (394 KB)
- Norwegian - NO (394 KB)
- Español - ES (394 KB)
- Swedish - SV (394 KB)
- Italian - IT (394 KB)
- Korean - KR (394 KB)
- Portuguese - PT (394 KB)
COA (2659 KB)
元素分析報告書 (2659 KB)
HNMR (2659 KB)
CNMR (2659 KB)
RP-HPLC (2659 KB)
NP-HPLC (2659 KB)
MS (2659 KB)
LCMS (2659 KB)
IR (2659 KB)
GC (2659 KB)
OR (2659 KB)
SDS-PAGE (2659 KB)
SEC-HPLC (2659 KB)
Other Report (2659 KB)
取扱説明書 (2659 KB)

参考文献

[1]. Kaminek M, et al. Cytokinin activities of N6-benzyladenosine derivatives hydroxylated on the side-chain phenyl ring. Journal of Plant Growth Regulation. 1987. 6(2):113.

[2]. Castiglioni S, et al. N6-isopentenyladenosine and its analogue N6-benzyladenosine induce cell cycle arrest and apoptosis in bladder carcinoma T24 cells. Anticancer Agents Med Chem. 2013 May;13(4):672-8. [Content Brief]

[3]. Mlejnek P. Caspase inhibition and N6-benzyladenosine-induced apoptosis in HL-60 cells. J Cell Biochem. 2001;83(4):678-89. [Content Brief]

[4]. Kim YA, et al. Synthesis, biological evaluation and molecular modeling studies of N6-benzyladenosine analogues as potential anti-toxoplasma agents. Biochem Pharmacol. 2007 May 15;73(10):1558-72. [Content Brief]

[5]. Grimaldi M, et al. NMR for screening and a biochemical assay: Identification of new FPPS inhibitors exerting anticancer activity. Bioorg Chem. 2020 May;98:103449. [Content Brief]

Help & FAQs

How should lyophilized recombinant proteins be reconstituted and stored?

1. Before opening the cap, centrifuge the vial at 13000 rpm for 20-30 seconds. This step will ensure that any lyophilized powder that may have adhered to the cap or walls is collected at the bottom of the vial, minimizing the risk of product loss.

Complete Stock Solution Preparation Table

Optional Solvent	Concentration Solvent Mass	1 mg	5 mg	10 mg	25 mg
DMSO	1 mM	2.7983 mL	13.9915 mL	27.9830 mL	69.9575 mL
	5 mM	0.5597 mL	2.7983 mL	5.5966 mL	13.9915 mL
	10 mM	0.2798 mL	1.3991 mL	2.7983 mL	6.9957 mL
	15 mM	0.1866 mL	0.9328 mL	1.8655 mL	4.6638 mL
	20 mM	0.1399 mL	0.6996 mL	1.3991 mL	3.4979 mL
	25 mM	0.1119 mL	0.5597 mL	1.1193 mL	2.7983 mL
	30 mM	0.0933 mL	0.4664 mL	0.9328 mL	2.3319 mL
	40 mM	0.0700 mL	0.3498 mL	0.6996 mL	1.7489 mL
	50 mM	0.0560 mL	0.2798 mL	0.5597 mL	1.3991 mL
	60 mM	0.0466 mL	0.2332 mL	0.4664 mL	1.1660 mL
	80 mM	0.0350 mL	0.1749 mL	0.3498 mL	0.8745 mL
	100 mM	0.0280 mL	0.1399 mL	0.2798 mL	0.6996 mL

製品名:
製品番号:
数量:
日本の代理先をお選びください:

製品名:
CAS 番号:
生物種:
純度:
数量:

N6-Benzyladenosine

Bioactive Compound Library Max

Bioactive Compound Library

Anti-Infection Compound Library

Apoptosis Compound Library

GPCR/G Protein Compound Library

Natural Product Library

Anti-Cancer Compound Library

Small Molecule Immuno-Oncology Compound Library

Nucleotide Compound Library

Neurotransmitter Receptor Compound Library

Anti-Cancer Natural Product Library

Plant-Sourced Natural Product Library

Membrane Protein-targeted Compound Library

Membrane Receptor-targeted Compound Library

Cell Death Library

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Anti-Brain Cancer Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

RO5 Drug-like Natural Product Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Plant Hormone Library

Natural Product Diversity Scaffold Library

Lactylation Compound Library

Mass Spectrometry Natural Product Library

Adenosine Receptor アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

N6-Benzyladenosine

Bioactive Compound Library Max

Bioactive Compound Library

Anti-Infection Compound Library

Apoptosis Compound Library

GPCR/G Protein Compound Library

Natural Product Library

Anti-Cancer Compound Library

Small Molecule Immuno-Oncology Compound Library

Nucleotide Compound Library

Neurotransmitter Receptor Compound Library

Anti-Cancer Natural Product Library

Plant-Sourced Natural Product Library

Membrane Protein-targeted Compound Library

Membrane Receptor-targeted Compound Library

Cell Death Library

MCE Bioactive Compound Library

Natural Product Library Plus

Natural Product and Natural Product-Like Compound Library

Anti-Brain Cancer Compound Library

Non-Alcoholic Fatty Liver Disease (NAFLD) Compound Library

RO5 Drug-like Natural Product Library

High-Throughput Bioactive Compound Library

High-Throughput Natural Product Library

Plant Hormone Library

Natural Product Diversity Scaffold Library

Lactylation Compound Library

Mass Spectrometry Natural Product Library

Adenosine Receptor アイソフォーム固有の製品をすべて表示

生物活性

化学情報

溶剤 & 溶解度

純度とドキュメンテーション

参考文献

Help & FAQs

Complete Stock Solution Preparation Table

N6-Benzyladenosine 関連分類

HY-N7844 関連分類